PEGASYS, also known by its generic name peginterferon alfa-2a, is a medication primarily used in the treatment of chronic hepatitis B and C infections. It belongs to a class of drugs known as interferons, which are naturally occurring proteins that modulate the body's immune response. PEGASYS works by stimulating the immune system to fight off the virus, thereby reducing the viral load in the body and helping to prevent the virus from multiplying. This medication is administered through subcutaneous injection, typically on a weekly basis. It is important for patients to be closely monitored by healthcare professionals during treatment due to potential side effects, which can include flu-like symptoms, fatigue, and mood changes. PEGASYS has been a key component in the management of chronic hepatitis, offering patients a chance to control infections and reduce the risk of developing further liver complications.